Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.
about
Evolution of lymphoma staging and response evaluation: current limitations and future directions.High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance).R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.Maintenance therapy following induction chemoimmunotherapy in patients with diffuse large B-cell lymphoma: current perspective.Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas.Intensified therapy in diffuse large B-cell lymphoma.
P2860
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Randomized Trial Comparing R-C ...... iffuse Large B-Cell Lymphomas.
@en
type
label
Randomized Trial Comparing R-C ...... iffuse Large B-Cell Lymphomas.
@en
prefLabel
Randomized Trial Comparing R-C ...... iffuse Large B-Cell Lymphomas.
@en
P2093
P50
P356
P1476
Randomized Trial Comparing R-C ...... Diffuse Large B-Cell Lymphomas
@en
P2093
Alessandro Massimo Gianni
Alessandro Rambaldi
Andrea Rossi
Andrés J M Ferreri
Anna Maria Barbui
Antonino Mulé
Arianna Masciulli
Atto Billio
Caterina Patti
Claudia Castellino
P304
P356
10.1200/JCO.2016.67.2980
P407
P50
P577
2016-10-31T00:00:00Z